Karyopharm Therapeutics Inc. (KPTI) — SC 13G/A Filings
All SC 13G/A filings from Karyopharm Therapeutics Inc.. Browse 9 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (9)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 4, 2024
- SC 13G/A Filing — Jul 8, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
Rubric Capital Exits Karyopharm Therapeutics Position
— Feb 12, 2024 Risk: medium
Rubric Capital Management LP, a Delaware-based investment firm, filed an amended SC 13G/A on February 12, 2024, indicating a significant change in its holdings -
BlackRock Amends Karyopharm Stake, Maintains Passive Position
— Jan 25, 2024
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Karyopharm Therapeutics Inc. common stock as of December 31, 2023. Thi -
State Street Corp. Updates Karyopharm Therapeutics Stake
— Jan 22, 2024
State Street Corporation, a major financial institution, filed an amended Schedule 13G/A on January 22, 2024, indicating its ownership of Karyopharm Therapeutic
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX